Determination of a New 5-Lipoxygenase Inhibitor, Zileuton, and its Inactive N-Dehydroxylated Metabolite in Plasma by High Performance Liquid Chromatography G. Richard GrannemanRene A. BraeckmanKeith A. Erdman OriginalPaper 25 October 2012 Pages: 1 - 8
The Pharmacokinetics of Single Oral Doses of Zileuton 200 to 800mg, its Enantiomers, and its Metabolites, in Normal Healthy Volunteers Shekman L. WongWalid M. AwniLouise M. Dubé OriginalPaper 25 October 2012 Pages: 9 - 21
Pharmacokinetics and Pharmacodynamics of Zileuton after Oral Administration of Single and Multiple Dose Regimens of Zileuton 600mg in Healthy Volunteers Walid M. AwniRene A. BraeckmanLouise M. Dubé OriginalPaper 25 October 2012 Pages: 22 - 33
In Vitro Plasma Protein Binding of Zileuton and its N-Dehydroxylated Metabolite Joseph M. MachinistMichael J. KukulkaBarbara A. Bopp OriginalPaper 25 October 2012 Pages: 34 - 41
The Pharmacokinetics of Zileuton in Healthy Young and Elderly Volunteers Rene A. BraeckmanG. Richard GrannemanWalid M. Awni OriginalPaper 25 October 2012 Pages: 42 - 48
The Effect of Mild or Moderate Hepatic Impairment (Cirrhosis) on the Pharmacokinetics of Zileuton Walid M. AwniJohn H. CavanaughG. Richard Granneman OriginalPaper 25 October 2012 Pages: 49 - 61
The Effect of Food on the Pharmacokinetics of Zileuton Walid M. AwniJohn H. CavanaughLouise M. Dubé OriginalPaper 25 October 2012 Pages: 62 - 66
Pharmacodynamic and Stereoselective Pharmacokinetic Interactions between Zileuton and Warfarin in Humans Walid M. AwniZiad HusseinJohn H. Cavanaugh OriginalPaper 25 October 2012 Pages: 67 - 76
Effect of Zileuton on Theophylline Pharmacokinetics G. Richard GrannemanRene A. BraeckmanWalid M. Awni OriginalPaper 25 October 2012 Pages: 77 - 83
Lack of Pharmacokinetic Interaction between Zileuton and Phenytoin in Humans Emil SamaraJohn H. CavanaughG. Richard Granneman OriginalPaper 25 October 2012 Pages: 84 - 91
Assessment of the Pharmacokinetic Interaction between Zileuton and Digoxin in Humans Walid M. AwniZiad HusseinLouise M. Dubé OriginalPaper 25 October 2012 Pages: 92 - 97
The Influence of Multiple Oral Doses of Zileuton on the Steady-State Pharmacokinetics of Sulfasalazine and its Metabolites, Sulfapyridine and N-Acetylsulfapyridine Walid M. AwniRene A. BraeckmanG. Richard Granneman OriginalPaper 25 October 2012 Pages: 98 - 104
Pharmacokinetic Interactions between Zileuton and Prednisone Walid M. AwniJohn H. CavanaughLouise M. Dubé OriginalPaper 25 October 2012 Pages: 105 - 111
The Pharmacokinetic and Pharmacodynamic Interactions between the 5-Lipoxygenase Inhibitor Zileuton and the Cyclo-Oxygenase Inhibitor Naproxen in Human Volunteers Walid M. AwniRene A. BraeckmanLouise M. Dubé OriginalPaper 25 October 2012 Pages: 112 - 124
